NMPA Issues Immediate Guidelines for NGS-Related IVD Reagent Classification
China’s National Medical Products Administration (NMPA) released the “Guidelines for Classification Definition of Next-Generation Sequencing...
NMPA
China Issues Whistleblower Incentives for Drug and Medical Device Safety Violations
China’s National Medical Products Administration (NMPA), Ministry of Finance (MoF), and State Administration for Market...
NMPA Releases Updated List of Medical Devices Exempted from Clinical Evaluation
The National Medical Products Administration (NMPA) has released the latest version of the “List of...
China’s NMPA Releases Draft Guidelines for Development Risk Management Plan
The Center for Drug Evaluation (CDE) of China’s National Medical Products Administration (NMPA) released the...
NMPA Issues New Quality Management Standards for Online Medical Device Sales
The National Medical Products Administration (NMPA) has released the “Announcement on Quality Management Standards for...
NMPA Issues 91st Batch of Reference Standards for Generic Drug Quality Evaluation
The National Medical Products Administration (NMPA) has released the 91st batch of reference standards for...
NMPA Optimizes Drug Manufacturing License Process with Digital QR Codes
The National Medical Products Administration (NMPA) has announced new measures to optimize the drug manufacturing...
China Proposes New Measures to Optimize High-End Medical Device Regulation
The National Medical Products Administration (NMPA) has released the “Measures for Optimizing Full Lifecycle Supervision...
China Tightens Medical Device Quality Oversight: 2025 Inspection Plan Unveiled
China’s National Medical Products Administration (NMPA) has released its 2025 medical device inspection plan, outlining...
China Unveils 2025 Medical Device Inspection Strategy to Tighten Quality Control
China’s National Medical Products Administration (NMPA) convened a pivotal conference in Chengdu on March 24...
China’s 2025 Pharmacopoeia Edition Approved, Set for October 1 Implementation
The Pharmacopoeia of the People’s Republic of China (2025 Edition), released by the National Medical...
NMPA Updates Rules on Domestic Production of Imported Medical Devices
The National Medical Products Administration (NMPA) has released a notification on further adjusting and optimizing...
Acotec Scientific’s Vericor Catheter Wins NMPA Approval for Peripheral Vascular Surgery
China-based Acotec Scientific Holdings Ltd (HKG: 6669) announced that its peripheral disposable support catheter Vericor...
NMPA’s New Guidelines for Drug Registration Review
A Look at the New Rules for Chemical and Biological Drug Filings in China:The Center...
NMPA Seeks Public Feedback on Export Drug Manufacturing Rules
An In – Depth Look at the New Draft Proposal for the Administration and Management...
NMPA Implements Regulatory Reforms for Drug and Medical Device Industries
The National Medical Products Administration (NMPA) has released a notification regarding the implementation of the...
NMPA Releases 89th Batch of Reference Drugs for GQCE Work
The National Medical Products Administration (NMPA) has released the 89th batch of reference drugs for...
NMPA Releases 88th Batch of Reference Drugs for Generic Quality Consistency Evaluation
The National Medical Products Administration (NMPA) has released the 88th batch of reference drugs for...
NMPA Releases 87th Batch of Reference Drugs for Generic Quality Consistency
The National Medical Products Administration (NMPA) has released the 87th batch of reference drugs for...
NMPA Proposes Draft for Simplified Registration of Traditional Chinese Medicines from Hong Kong and Macao
The National Medical Products Administration (NMPA) has issued the “Notification on Simplifying the Registration and...